Home
Medicines
Active Ingredients
Companies
DHPC
Advanced Search
Side Effect Reporting
Login
Medicines.ie | Reliable & Accurate Online Medicines Information | Home page
Home Medicines Active Ingredients Companies DHPC Advanced Search Side Effect Reporting
Login
  • Home
  • Active Ingredients
  • Tisagenlecleucel Cell Dispersion

Tisagenlecleucel Cell Dispersion

Medicine Status Monitoring SPC PIL XPIL Legal Category Active Ingredient(s) Company
Kymriah 1.2 x 106 – 6 x 108 cells dispersion for infusion
DHPC
Updated
SPC PIL No A
Tisagenlecleucel Cell Dispersion
Novartis Ireland Limited

Brought to you by

Irish Pharmaceutical Healthcare Association | Home page

About

  • Help
  • About
  • Contact Us

Legal

  • Privacy Statement
  • Terms & Conditions
  • Accessibility

Search

  • Medicines
  • Active Ingredients
  • Companies

Award

Pharma Industry Awards 2020, Innovation of the Year, 2nd Place
Designed by eConcept Web Solutions
Direct Healthcare Professional Communications
A direct healthcare professional communication (DHPC) is for healthcare professionals to inform them of important new safety information about a medicine and any actions they should take.
Documents associated with this medicine were updated in the last 30 days.
Black Inverted Triangle: This medicinal product is subject to additional monitoring.
Product subject to medical prescription which may not be renewed (A)